✦ LIBER ✦

Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes

✍ Scribed by Ahmad, Shiekh Tanveer; Arjumand, Wani; Seth, Amlesh; Nafees, Sana; Rashid, Summya; Ali, Nemat; Hamiza, Oday O.; Sultana, Sarwat

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Implication of Xenobiotic Metabolizing E

✍ Achraf Khedhaier; Elham Hassen; Noureddine Bouaouina; Sallouha Gabbouj; Slim Ben 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 319 KB

Genetic polymorphisms of metabolic enzym

✍ Ya-ping Luo; Han-chun Chen; Md. Asaduzzaman Khan; Fang-zhi Chen; Xin-xing Wan; B 📂 Article 📅 2010 🏛 S. Karger AG 🌐 English ⚖ 206 KB

Genetic polymorphisms of drug-metabolizi

✍ D. Krishnakumar; Umamaheswaran Gurusamy; Kayathri Dhandapani; A. Surendiran; Ruc 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Polymorphisms of drug-metabolizing enzym

✍ Elena A. Gaikovitch; Ingolf Cascorbi; Przemyslaw M. Mrozikiewicz; Jürgen Brockmö 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 233 KB

Genetic Polymorphism of Drug Metabolizin

✍ Tsuyoshi Yokoi; Tetsuya Kamataki 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 877 KB

CYP1A1 and CYP2D6 polymorphism and risk

✍ C. Sobti, R.; Sharma, S.; Joshi, A.; K. Jindal, S.; Janmeja, A. 📂 Article 📅 2003 🏛 Informa plc 🌐 English ⚖ 155 KB